â‚©
13000.00
Jun 21
Business Description
Il Yang Pharmaceutical Co Ltd
SIC : 2836
ISIN : KR7007571003
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | 4.36 | |||||
Interest Coverage | 6.24 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.59 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.6 | |||||
3-Year EBITDA Growth Rate | -22.7 | |||||
3-Year FCF Growth Rate | -39.2 | |||||
3-Year Book Growth Rate | 3.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 1.2 | |||||
9-Day RSI | 6.03 | |||||
14-Day RSI | 12.69 | |||||
6-1 Month Momentum % | -6.31 | |||||
12-1 Month Momentum % | -16.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.9 | |||||
Quick Ratio | 0.53 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 146.44 | |||||
Days Sales Outstanding | 58.84 | |||||
Days Payable | 66.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.35 | |||||
3-Year Dividend Growth Rate | 7.7 | |||||
Forward Dividend Yield % | 1.35 | |||||
5-Year Yield-on-Cost % | 1.3 | |||||
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | -0.72 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.33 | |||||
Operating Margin % | 6.29 | |||||
Net Margin % | -0.93 | |||||
ROE % | -1.51 | |||||
ROA % | -0.74 | |||||
ROIC % | -0.78 | |||||
ROC (Joel Greenblatt) % | 3.28 | |||||
ROCE % | 2.78 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 36.31 | |||||
PS Ratio | 0.64 | |||||
PB Ratio | 1.03 | |||||
Price-to-Free-Cash-Flow | 16.69 | |||||
Price-to-Operating-Cash-Flow | 8.68 | |||||
EV-to-EBIT | 37.99 | |||||
EV-to-EBITDA | 14.32 | |||||
EV-to-Revenue | 0.82 | |||||
EV-to-FCF | 21.03 | |||||
Earnings Yield (Greenblatt) % | 2.63 | |||||
FCF Yield % | 6.17 | |||||
Forward Rate of Return (Yacktman) % | 11.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Il Yang Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | |||
EPS (TTM) (â‚©) | 0 | ||
Beta | 1.14 | ||
Volatility % | 30.77 | ||
14-Day RSI | 12.69 | ||
14-Day ATR (â‚©) | 222.482282 | ||
20-Day SMA (â‚©) | 14239.5 | ||
12-1 Month Momentum % | -16.9 | ||
52-Week Range (â‚©) | 13000 - 19400 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Il Yang Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Il Yang Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Il Yang Pharmaceutical Co Ltd Frequently Asked Questions
What is Il Yang Pharmaceutical Co Ltd(XKRX:007575.PFD)'s stock price today?
When is next earnings date of Il Yang Pharmaceutical Co Ltd(XKRX:007575.PFD)?
Does Il Yang Pharmaceutical Co Ltd(XKRX:007575.PFD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |